Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2025 ARTÍCULOS , VIENDO DEL 136 AL 150

Targeting together cholinesterases and serotonin reuptake against Alzheimer's disease

Guiselin T, Lecoutey C, Rochais C, Dallemagne P.

J Pharm Pharmacol. 2025 Oct 1;77(10):1303-1318. doi: 10.1093/jpp/rgaf041.

Signs of Alzheimer's Disease: Tied to Aging

Chen J, Zhu Z, Xu Y.

Int J Mol Sci. 2025 May 22;26(11):4974. doi: 10.3390/ijms26114974.

Serotonergic Regulation in Alzheimer's Disease

Dolgacheva LP, Zinchenko VP, Nadeev AD, Goncharov NV.

Int J Mol Sci. 2025 May 29;26(11):5218. doi: 10.3390/ijms26115218.

Iron-Mediated Overexpression of Amyloid Precursor Protein via Iron Responsive mRNA in Alzheimer's Disease

Khan MA.

Int J Mol Sci. 2025 May 30;26(11):5283. doi: 10.3390/ijms26115283.

Preclinical Evidence of Withania somnifera and Cordyceps spp.: Neuroprotective Properties for the Management of Alzheimer's Disease

Tancreda G, Ravera S, Panfoli I.

Int J Mol Sci. 2025 Jun 4;26(11):5403. doi: 10.3390/ijms26115403.

Advancing the science of recruitment for Alzheimer's clinical trials: Challenges and opportunities

Aisen P, Peneva D, Manetas MA, Jacobson M, Goldman D, Bose N, Ferrell PB, Vu VK, Raman R.

J Prev Alzheimers Dis. 2025 Aug;12(7):100230. doi: 10.1016/j.tjpad.2025.100230. Epub 2025 Jun 12.

Memory Gate Controlled by Contexts: Potential Key Structure That Could Link Small Associative Failures With Severe Cognitive Disorders

Mizraji E, Lin J, Pomi A.

Bioessays. 2025 Aug;47(8):e70032. doi: 10.1002/bies.70032. Epub 2025 Jun 16.

Bilirubin: a game-changer in alzheimer's therapy? Unveiling its neuroprotective and disease-modifying potential

Sidhu RK, Mittal Y, Aran KR.

Metab Brain Dis. 2025 Jun 16;40(6):224. doi: 10.1007/s11011-025-01653-3.

Pyroptosis in Alzheimer's Disease: Mechanisms and Therapeutic Potential

Tang T.

Cell Mol Neurobiol. 2025 Jun 17;45(1):57. doi: 10.1007/s10571-025-01579-5.

Histone Deacetylase Inhibition in Alzheimer's Disease: Molecular Mechanisms, Therapeutic Potential, and Future Perspectives

Joshi N, Khadse P, Jadhav S, Alavala RR.

Curr Top Med Chem. 2025;25(28):3215-3233. doi: 10.2174/0115680266360664250606110220.

Microglia energy metabolism: A new perspective on Alzheimer's disease treatment

Wu QL, Yang X, Luo JX, Liu L, Zhou Y, Lu MH.

J Neurol Sci. 2025 Aug 15;475:123585. doi: 10.1016/j.jns.2025.123585. Epub 2025 Jun 16.

Recent Progress of Small-molecule Inhibitors of O-GlcNAcase for Alzheimer's Disease

Sun S, Cao J, Ji S, Wang J.

Mini Rev Med Chem. 2025;25(11):821-837. doi: 10.2174/0113895575376839250606183944.

Autoantibodies in Alzheimer's disease: Multifaceted roles and therapeutic horizons

Gong J, Li S, Han X, Wang P, Sun W, Xu C, Luan H, Wen B, Guo J, Wei C.

J Alzheimers Dis. 2025 Aug;106(4):1219-1231. doi: 10.1177/13872877251350292. Epub 2025 Jun 22.

Potential Applications of Natural Components of Traditional Chinese Medicine Delivery via Nanoparticle Drug Delivery Systems in the Treatment of Alzheimer's Disease

Lai G, Wu H, Yang K, Hu K, Zhao W, Chen X, Li J, Wang H, Lv Z, Xie G, Wu X.

Int J Nanomedicine. 2025 Jun 17;20:7781-7810. doi: 10.2147/IJN.S525960. eCollection 2025.

Beyond Transgenic Mice: Emerging Models and Translational Strategies in Alzheimer's Disease

Alexandra Lopes P, Guil-Guerrero JL.

Int J Mol Sci. 2025 Jun 10;26(12):5541. doi: 10.3390/ijms26125541.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias